The global In Silico Drug Discovery Market is forecasted to be worth USD 6.34 Billion by 2027, according to a current analysis by Emergen Research. The constant increase in the number of patients suffering from chronic diseases and pharmaceutical companies investing heavily in the development of various drugs are also influencing the market growth. The In silico drug discovery process help in the design and development of novel products.
The in silico drug market is growing, and several pharmaceutical companies are focusing on the development of drugs using computer-aid. The pharma companies are taking advantage of the technology to discover drugs for more complex diseases. The in silico drug discovery is used in early preclinical research and development of small molecule drugs and in clinical candidates in various stages of medicine. Due to the advancement in information technology and innovative breakthroughs in computational chemistry, several new drug compounds are being discovered through this procedure.
A new market assessment report on in silico drug market brings to light a detailed statistics on the dramatic shift in the competitive landscape and business environment of the in silico drug market for the forecast period 2020 - 2027. The comprehensive study offers an overview of the current state of development of the business as well as predicts the course of progress across different regions. A large number of factors including the major driving forces, threats and opportunities are taken into account to present an analytical picture of the industry portrayed in the report.
Read more@ https://www.emergenresearch.com/industry-report/in-silico-drug-discovery-market
Key Highlights From The Report
In November 2020, Lead Pharma announced its collaboration and license agreement with Roche for the development of oral small molecules for the treatment of a broad range of immune-mediated diseases. Lead Pharma is using in silico lab for their computational chemistry, bioinformatics, and data mining activities.
The in silico molecular techniques are gaining popularity to engineer antibodies. It is used for the design of antibodies, including structure modeling, antibody stability evaluation, antibody-antigen complex prediction, and allosteric effects in antibodies and functions.
Computer-aided drug methodologies are playing a crucial role in the discovery of the drugs. This method is used in limiting the usage of animal models in pharmaceutical research, aid in the design of innovative and safe drug candidates, and supporting pharmacologist and medicinal chemist.
Usage of information technology in drug discovery is witnessing lucrative growth in the Asia Pacific region due to a rise in R&D activities and development in the biotechnology and pharmaceutical sectors. Moreover, the presence of a significant patient pool will fuel the demand for better healthcare services, which will drive the demand for the market.
Key participants include Certara USA, Inc., Albany Molecular Research Inc., Chemical Computing Group ULC, Charles River, Dassault System (Biovia), Collaborative Drug Discovery Inc., Evotec A.G., ICAGEN, Inc., GVK Biosciences Private Limited, and Novo Informatics Pvt. Ltd., among others.
Request For Free Sample@ https://www.emergenresearch.com/request-sample/373
Workflow Outlook (Revenue, USD Billion; 2017-2027)
Discovery
Target Identification
Reverse Docking
Bioinformatics
Protein Structure Prediction
Target Validation
Lead Discovery
Pharmacophore
Library Design
Preclinical Tests
Clinical Trials
Product Outlook (Revenue, USD Billion; 2017-2027)
Consultancy as a Service
Software as a Service (Cloud)
Software
Type of Large Molecule Outlook (Revenue, USD Billion; 2017-2027)
Proteins
Antibodies
Nucleic Acids
Peptides
Vectors
End-User Outlook (Revenue, USD Billion; 2017-2027)
Contract Research Organizations
Pharmaceutical Industry
Academic and Research Institutes
Others
Regional Outlook (Revenue, USD Billion; 2017-2027)
North America
Europe
Asia Pacific
Latin America
MEA
Table of Content
Chapter 1. Methodology & Sources
1.1. In Silico Drug Discovery Market Definition
1.2. In Silico Drug Discovery Market Research Scope
1.3. In Silico Drug Discovery Market Methodology
1.4. In Silico Drug Discovery Market Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. In Silico Drug Discovery Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027
Chapter 3. Key Insights
Chapter 4. In Silico Drug Discovery Market Segmentation & Impact Analysis
Continued…
